Skip to main content
UHS logo

UHS · Universal Health Services Inc

Track UHS — free
$170.02 -1.19 (-0.70%) At close · Aug 14
Market Cap
$10.02B
Shares
58.94M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$17.36B +9.7%
FY2025 Revenue FY2010–FY2025
Net Income
$1.49B +30.4%
FY2025 Net Income FY2008–FY2025
Operating Margin
11.48% +0.8pp
FY2025 Operating Margin FY2010–FY2025
Diluted EPS
$23.10 +37.3%
FY2025 Diluted EPS FY2008–FY2025
Operating Cash Flow
$1.86B -9.8%
FY2025 Operating Cash Flow FY2008–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010 FY2009 FY2008
$18.11B $17.36B $15.83B $14.28B $13.4B $12.64B $11.56B $11.38B $10.77B $10.41B $9.77B $9.04B $8.21B $7.37B $6.96B $6.76B $4.9B
$0 $0 $0 $0 $0 $0 $0 $0
$641.16M $618.74M $584.83M $568.04M $581.86M $533.21M $510.49M $490.39M $453.05M $447.77M $416.61M $398.62M $375.62M $337.36M $308.69M $295.86M $224M $204.7M $195.77M
$16.06B $15.37B $14.15B $13.11B $12.4B $11.28B $10.2B $10.16B $9.6B $9.13B $8.48B $7.78B $7.14B $6.35B $6.02B $5.86B $4.39B $4.68B $4.61B
$2.06B $1.99B $1.68B $1.18B $1B $1.36B $1.36B $1.22B $1.18B $1.28B $1.28B $1.26B $1.06B $1.02B $942.58M $897.13M $505.71M $520.53M $410.22M
11.48% 10.63% 8.23% 7.49% 10.78% 11.75% 10.69% 10.91% 12.3% 13.12% 13.93% 12.96% 13.78% 13.54% 13.27% 10.32%
$2.7B $2.61B $2.27B $1.74B $1.59B $1.9B $1.87B $1.71B $1.63B $1.73B $1.7B $1.66B $1.44B $1.35B $1.25B $1.19B $729.71M $725.24M $605.99M
$157.69M $156.07M $186.11M $206.67M $126.89M $83.67M $106.29M $162.73M $154.96M $145.17M $125.05M $113.49M $133.64M $146.13M $178.92M $200.79M $77.62M $45.81M $53.21M
$125.81M $134.19M $2.23M -$28.28M -$10.41M $13.89M $14K $13.16M $14.22M $0 $0
$93.29M $0 $0
$2.03B $1.97B $1.5B $940.43M $866.26M $1.29B $1.25B $1.07B $1.03B $1.14B $1.16B $1.15B $929.67M $869.33M $763.66M $696.34M $428.1M $474.72M $357.01M
$476.36M $460.96M $334.83M $221.12M $209.28M $305.68M $299.29M $238.79M $236.64M $363.7M $409.19M $395.2M $324.67M $315.31M $274.62M $247.47M $152.3M $170.48M $123.38M
$1.53B $1.49B $1.14B $717.8M $675.61M $991.59M $943.95M $814.85M $779.71M $752.3M $702.41M $680.53M $545.34M $510.73M $443.45M $398.17M $230.18M $260.37M $199.38M
8.57% 7.22% 5.03% 5.04% 7.84% 8.17% 7.16% 7.24% 7.23% 7.19% 7.53% 6.65% 6.93% 6.37% 5.89% 4.7%
$24.18M $22.39M $21.01M $1.51M -$18.63M -$3.96M $8.84M $12.69M $18.18M $19.01M $44.76M $70.17M $59.65M $43.29M $45.6M $50.7M $45.61M $43.87M $40.69M
$1.53B $1.49B $1.14B $717.49M $674.86M $989.53M -$521K -$918K -$1.15M
$1.51B $1.53B $1.14B $736.75M $635.65M $973.76M $960.18M $842.51M $775.22M $784.9M $700.12M $682.63M $544.92M $530.08M $450.47M $367.13M $231.3M
USD/shares $23.42 $17.16 $10.35 $9.23 $11.99 $11.06 $9.16 $8.35 $7.86 $7.22 $6.89 $5.52 $5.21 $4.57 $4.09 $2.37 $2.65 $1.96
USD/shares $23.10 $16.82 $10.23 $9.14 $11.82 $10.99 $9.13 $8.31 $7.81 $7.14 $6.76 $5.42 $5.14 $4.53 $4.04 $2.34 $2.64 $1.96
shares 63.58M 66.55M 69.32M 73.12M 82.52M 85.06M 88.76M 93.28M 95.65M 97.21M 98.8M 98.83M 98.03M 96.82M 97.2M 96.79M 97.79M 101.22M
shares 64.46M 67.9M 70.13M 73.83M 83.69M 85.59M 89.04M 93.75M 96.33M 98.38M 100.69M 100.54M 99.36M 97.71M 98.54M 97.97M 98.28M 101.42M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2008–FY2025: $6.97B in buybacks, $688.17M in dividends.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
0.81×
Peer median 1.49×
EV/EBIT
7.16×
Peer median 17.35×
P/E (TTM)
6.94×
Peer median 18.71×

Peer medians compare against the 30 similar-size Medical Care Facilities companies (of 58 listed).

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Acute Care Hospital Services $9,925,907,000 $8,944,288,000 $8,081,402,000 $7,646,749,000 $7,108,254,000 $6,337,304,000 $6,164,560,000 $5,719,905,000
Behavioral Health Services $7,425,500,000 $6,873,090,000 $6,190,921,000 $5,729,758,000 $5,503,644,000 $5,208,722,000 $5,210,063,000 $5,038,874,000
State Medicaid Programs $56,000,000 $53,000,000 $73,000,000 $75,000,000 $74,000,000 $73,000,000 $78,000,000 $64,000,000
All Other Segments $13,422,000 $10,557,000 $9,653,000 $22,863,000 $30,219,000 $12,871,000 $3,636,000 $13,499,000

By Geography (USD)

Component FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017
United Kingdom $880,000,000 $761,000,000 $685,000,000 $688,000,000 $584,000,000 $554,000,000 $505,000,000 $429,000,000

By Product & Service (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Managed Care $4,902,096,000 $4,496,402,000 $4,211,194,000 $4,012,954,000 $3,957,027,000 $3,426,937,000 $3,634,817,000 $3,489,870,000
Medicaid $2,686,967,000 $2,252,030,000 $1,532,904,000 $1,512,396,000 $1,291,692,000 $1,202,632,000 $1,207,649,000 $1,183,618,000
Managed Medicaid $2,482,601,000 $2,303,938,000 $2,290,661,000 $2,206,855,000 $1,947,263,000 $1,715,439,000 $1,678,641,000 $1,530,005,000
Managed Medicare $2,080,278,000 $1,883,905,000 $1,714,055,000 $1,560,589,000 $1,362,962,000 $1,104,930,000 $1,047,759,000 $929,390,000
Medicare $1,856,404,000 $1,669,125,000 $1,607,405,000 $1,615,762,000 $1,654,119,000 $1,690,591,000 $1,889,245,000 $1,875,875,000
Other Patient Revenue and Adjustments, Net $1,240,278,000 $1,112,808,000 $981,203,000 $745,642,000 $843,200,000 $745,344,000 $696,566,000 $650,987,000
Other Non-Patient Revenue $1,114,849,000 $1,229,579,000 $1,183,430,000 $1,060,578,000 $898,129,000 $1,089,024,000 $669,751,000 $607,812,000
UK Revenue $1,001,356,000 $880,148,000 $761,124,000 $684,594,000 $687,725,000 $584,000,000 $553,831,000 $504,721,000
Key facts CIK 352915 CUSIP 913903100 13F (30d) 554 filings 536 filers Visit website Investor relations